{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:29:57Z","timestamp":1790281797771,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.autrev.2018.09.003","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T22:11:54Z","timestamp":1545084714000},"page":"192-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Novel autoantibodies in Sj\u00f6gren's syndrome: A comprehensive review"],"prefix":"10.1016","volume":"18","author":[{"given":"Eduardo","family":"Mart\u00edn-Nares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Hern\u00e1ndez-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2018.09.003_bb0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1568-9972(02)00121-0","article-title":"Pathogenesis of Sj\u00f6gren's syndrome","volume":"2","author":"Yamamoto","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.09.003_bb0010","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.autrev.2018.02.003","article-title":"Cytokine markers of B lymphocytes in minor salivary gland infiltrates in Sj\u00f6gren's syndrome","volume":"17","author":"Navarro-Mendoza","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.09.003_bb0015","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.semarthrit.2012.07.003","article-title":"The role of ectopic germinal centers in the immunopathology of primary Sj\u00f6gren's syndrome: a systematic review","volume":"42","author":"Risselada","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.09.003_bb0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.autrev.2016.12.006","article-title":"Sj\u00f6gren's syndrome-associated myositis with germinal Centre-like structures","volume":"16","author":"Espitia-Thibault","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.09.003_bb0025","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/art.39214","article-title":"Prediction of Sj\u00f6gren's syndrome years before diagnosis and identification of patients with early onset and severe disease course by autoantibody profiling","volume":"67","author":"Theander","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2018.09.003_bb0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.autrev.2010.09.001","article-title":"The meaning of anti- Ro and anti-La antibodies in primary Sj\u00f6gren's syndrome","volume":"10","author":"Hern\u00e1ndez-Molina","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.09.003_bb0035","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.rdc.2016.03.002","article-title":"Autoantibodies in Sj\u00f6gren's syndrome","volume":"42","author":"Fayyaz","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2018.09.003_bb0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaut.2012.03.001","article-title":"Subgroups of Sj\u00f6gren syndrome patients according to serological profiles","volume":"39","author":"Bournia","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2018.09.003_bb0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1568-9972(03)00002-8","article-title":"Antibodies against alpha-fodrin in Sjogren's syndrome","volume":"2","author":"Ulbricht","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.09.003_bb0050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2013.11.001","article-title":"A comprehensive review of autoantibodies in primary Sj\u00f6gren's syndrome: clinical phenotypes and regulatory mechanisms","volume":"51","author":"Kyriakidis","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2018.09.003_bb0055","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1016\/j.lpm.2012.05.019","article-title":"Pathogenic role of anti-M3 muscarinic acethylcholine receptor immune response in Sj\u00f6gren's syndrome","volume":"41","author":"Sumida","year":"2012","journal-title":"Presse Med"},{"key":"10.1016\/j.autrev.2018.09.003_bb0060","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.autrev.2017.02.010","article-title":"Neonatal lupus: follow-up in infants with anti-SSA\/Ro antibodies and review of the literature","volume":"16","author":"Zuppa","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.09.003_bb0065","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.autrev.2016.12.004","article-title":"Anti-Ro\/SSA and anti-La\/SSB antibodies: association with mild lupus manifestations in 645 childhood-onset systemic lupus erythematosus","volume":"16","author":"Novak","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.09.003_bb0070","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.autrev.2017.04.004","article-title":"Vitamin D and Sj\u00f6gren syndrome","volume":"16","author":"Garcia-Carrasco","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"177","key":"10.1016\/j.autrev.2018.09.003_bb0075","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.4049\/jimmunol.177.8.5676","article-title":"Development of autoimmunity in IL-14alpha-transgenic mice","volume":"15","author":"Shen","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.09.003_bb0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.clim.2012.09.013","article-title":"Novel autoantibodies in Sjogren's syndrome","volume":"145","author":"Shen","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2018.09.003_bb0085","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12886-017-0412-8","article-title":"Analysis of novel Sjogren's syndrome autoantibodies in patients with dry eyes","volume":"17","author":"Everett","year":"2017","journal-title":"BMC Ophthalmol"},{"issue":"15","key":"10.1016\/j.autrev.2018.09.003_bb0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12886-015-0023-1","article-title":"Investigation of novel autoantibodies in Sj\u00f6gren's syndrome utilizing Sera from the Sj\u00f6gren's international collaborative clinical alliance cohort","volume":"10","author":"Suresh","year":"2015","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.autrev.2018.09.003_bb0095","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.clim.2017.12.008","article-title":"Investigation of autoantibodies to SP-1 in Chinese patients with primary Sj\u00f6gren's syndrome","volume":"188","author":"Xuan","year":"2018","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2018.09.003_bb0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.clim.2014.08.009","article-title":"Evaluation of salivary gland protein 1 antibodies in patients with primary and secondary Sjogren's syndrome","volume":"155","author":"Shen","year":"2014","journal-title":"Clin Immunol"},{"issue":"17","key":"10.1016\/j.autrev.2018.09.003_bb0105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13075-015-0722-2","article-title":"Interferon gamma-inducible protein 16 in primary Sj\u00f6gren's syndrome: a novel player in disease pathogenesis?","volume":"14","author":"Alunno","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2018.09.003_bb0110","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/acr.22632","article-title":"Association of antibodies to interferon-inducible protein-16 with markers of more severe disease in primary Sj\u00f6gren's syndrome","volume":"68","author":"Baer","year":"2016","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2018.09.003_bb0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2567.2005.02197.x","article-title":"Identification of specific autoantigens in Sj\u00f6gren's syndrome by SEREX","volume":"116","author":"Uchida","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2018.09.003_bb0120","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1002\/art.22266","article-title":"A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16","volume":"54","author":"Mondini","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.09.003_bb0125","doi-asserted-by":"crossref","first-page":"963568","DOI":"10.1155\/2015\/963568","article-title":"Autoantibody to MDM2: a potential serological marker of systemic lupus erythematosus","volume":"2015","author":"Liu","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.autrev.2018.09.003_bb0130","doi-asserted-by":"crossref","first-page":"14306","DOI":"10.18632\/oncotarget.14882","article-title":"Autoantibody to MDM2: a potential serological marker of primary Sjogren's syndrome","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"273","key":"10.1016\/j.autrev.2018.09.003_bb0135","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1074\/jbc.273.3.1634","article-title":"NA14 is a novel nuclear autoantigen with a coiled-coil domain","volume":"16","author":"Ramos-Morales","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2018.09.003_bb0140","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.2741\/3484","article-title":"Autoantibody to NA14 is an independent marker primarily for Sjogren's syndrome","volume":"14","author":"Nozawa","year":"2009","journal-title":"Front Biosci"},{"key":"10.1016\/j.autrev.2018.09.003_bb0145","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/08916934.2016.1196676","article-title":"A re- evaluation of anti-NA-14 antibodies in patients with primary Sj\u00f6gren's syndrome: significant role of interferon-\u03b3 in the production of autoantibodies against NA-14","volume":"49","author":"Uomori","year":"2016","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2018.09.003_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2014.09.002","article-title":"Neuronal stathmins: a family of phosphoproteins cooperating for neuronal development, plasticity and regeneration","volume":"126","author":"Chauvin","year":"2015","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.autrev.2018.09.003_bb0155","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s12026-017-8970-7","article-title":"Autoantibodies binding to stathmin-4: new marker for polyneuropathy in primary Sj\u00f6gren's syndrome","volume":"65","author":"Duda","year":"2017","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2018.09.003_bb0160","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9440(10)64866-3","article-title":"Stathmin-deficient mice develop an age-dependent axonopathy of the central and peripheral nervous systems","volume":"160","author":"Liedtke","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2018.09.003_bb0165","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/annrheumdis-2015-207509","article-title":"PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sj\u00f6gren's syndrome","volume":"75","author":"Fiorentino","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.09.003_bb0170","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2018.09.003_bb0175","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.autrev.2016.12.002","article-title":"Clinical utility of circulating anti-N-methyl-D- aspartate receptor subunits NR2A\/B antibody for the diagnosis of neuropsychiatric syndromes in systemic lupus erythematosus and Sj\u00f6gren's syndrome: an updated meta-analysis","volume":"16","author":"Tay","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.09.003_bb0180","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1002\/art.38127","article-title":"Memory dysfunction in primary Sj\u00f6gren's syndrome is associated with anti-NR2 antibodies","volume":"65","author":"Lauvsnes","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.09.003_bb0185","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1002\/art.38852","article-title":"Association of hippocampal atrophy with cerebrospinal fluid antibodies against the NR2 subtype of the N-methyl-D-aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sj\u00f6gren's syndrome","volume":"66","author":"Lauvsnes","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2018.09.003_bb0190","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/art.39497","article-title":"Brief report: patients with primary Sj\u00f6gren's syndrome who are positive for autoantibodies to tripartite motif-containing protein 38 show greater disease severity","volume":"68","author":"Wolska","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2018.09.003_bb0195","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12016-012-8344-9","article-title":"Anti- saccharomyces cerevisiae autoantibodies in autoimmune diseases: from bread baking to autoimmunity","volume":"45","author":"Rinaldi","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"issue":"Suppl. 112","key":"10.1016\/j.autrev.2018.09.003_bb0200","first-page":"73","article-title":"Prevalence and significance of anti-saccharomyces cerevisiae antibodies in primary Sj\u00f6gren's syndrome","volume":"36","author":"Alunno","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2018.09.003_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/art.40550","article-title":"Anti- calponin-3 autoantibodies: a new specificity in patients with Sj\u00f6gren's syndrome","author":"Birnbaum","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2018.09.003_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118312","article-title":"Clinical features of autoimmune autonomic ganglionopathy and the detection of subunit- specific autoantibodies to the ganglionic acetylcholine receptor in Japanese patients","volume":"10","author":"Nakane","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.09.003_bb0215","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3109\/14397595.2016.1147404","article-title":"Insights from the ganglionic acetylcholine receptor autoantibodies in patients with Sj\u00f6gren's syndrome","volume":"26","author":"Mukaino","year":"2016","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2018.09.003_bb0220","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrd4226","article-title":"Aquaporins: important but elusive drug targets","volume":"13","author":"Verkman","year":"2014","journal-title":"Nat Rev Drug Discov"},{"issue":"357","key":"10.1016\/j.autrev.2018.09.003_bb0225","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0140-6736(00)04140-4","article-title":"Defective cellular trafficking of lacrimal gland aquaporin-5 in Sj\u00f6gren's syndrome","volume":"3","author":"Tsubota","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2018.09.003_bb0230","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/01.LAB.0000038502.42845.9E","article-title":"Selective down-regulation of aquaporin-1 in salivary glands in primary Sj\u00f6gren's syndrome","volume":"82","author":"Beroukas","year":"2002","journal-title":"Lab Invest"},{"key":"10.1016\/j.autrev.2018.09.003_bb0235","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica and non-organ-specific autoimmunity","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2018.09.003_bb0240","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/1352458508088941","article-title":"Minor salivary gland inflammation in Devic's disease and longitudinally extensive myelitis","volume":"14","author":"Javed","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2018.09.003_bb0245","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/1352458511403958","article-title":"Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders","volume":"17","author":"Jarius","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2018.09.003_bb0250","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/acr.23107","article-title":"Relationship between neuromyelitis optica spectrum disorder and Sj\u00f6gren's Syndrome: central nervous system extraglandular disease or unrelated, co- occurring autoimmunity?","volume":"69","author":"Birnbaum","year":"2017","journal-title":"Arthritis Care Res"},{"issue":"274","key":"10.1016\/j.autrev.2018.09.003_bb0255","doi-asserted-by":"crossref","first-page":"20071","DOI":"10.1074\/jbc.274.29.20071","article-title":"Defective secretion of saliva in transgenic mice lacking aquaporin-5 water channels","volume":"16","author":"Ma","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2018.09.003_bb0260","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s12026-016-8786-x","article-title":"Detection of autoantibodies against aquaporin-5 in the sera of patients with primary Sj\u00f6gren's syndrome","volume":"64","author":"Alam","year":"2016","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2018.09.003_bb0265","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1177\/0022034517717965","article-title":"Functional epitopes for anti-aquaporin 5 antibodies in Sj\u00f6gren syndrome","volume":"96","author":"Alam","year":"2017","journal-title":"J Dent Res"},{"key":"10.1016\/j.autrev.2018.09.003_bb0270","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/rheumatology\/kex328","article-title":"Antibodies to aquaporins are frequent in patients with primary Sj\u00f6gren's syndrome","volume":"56","author":"Tzartos","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2018.09.003_bb0275","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.12659\/MSM.895144","article-title":"Elevated plasma P- selectin autoantibodies in primary Sj\u00f6gren syndrome patients with thrombocytopenia","volume":"21","author":"Hu","year":"2015","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.autrev.2018.09.003_bb0280","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/annrheumdis-2015-207751","article-title":"Antibodies against carbamylated proteins are present in primary Sj\u00f6gren's syndrome and are associated with disease severity","volume":"75","author":"Bergum","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.09.003_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/0929866525666180320110135","article-title":"Identification of moesin as a novel autoantigen in patients with Sj\u00f6gren's syndrome","volume":"25","author":"Zhang","year":"2018","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.autrev.2018.09.003_bb0290","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.autrev.2018.02.003","volume":"17","author":"Giacomelli","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.09.003_bb0295","doi-asserted-by":"crossref","first-page":"30039","DOI":"10.18632\/oncotarget.15613","article-title":"Investigation of three potential auoantibodies in Sjogren's syndrome and associated MALT lymphoma","volume":"8","author":"Cui","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.autrev.2018.09.003_bb0300","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.clim.2017.09.012","article-title":"Antibodies against citrullinated alpha enolase peptides in primary Sjogren's syndrome","volume":"183","author":"Nezos","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2018.09.003_bb0305","article-title":"\u03b1-enolase is an antigenic target in primary Sj\u00f6gren's syndrome","author":"Olivares-Mart\u00ednez","year":"2018","journal-title":"Clin Exp Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218302921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218302921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:14:34Z","timestamp":1761599674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997218302921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1568997218302921"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2018.09.003","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel autoantibodies in Sj\u00f6gren's syndrome: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2018.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}